Aims/hypothesis There is evidence that ATP acts as an autocrine signal in beta cells but the receptors and pathways involved are incompletely understood. Here we investigate the receptor subtype(s) and mechanism(s) mediating the effects of ATP on human beta cells. 
] i by stimulating Ca 2+ influx and evoking Ca 2+ release via InsP 3 -receptors in the endoplasmic reticulum (ER). ATPevoked Ca 2+ release was sufficient to trigger exocytosis in cells voltage-clamped at −70 mV. All effects of ATP were mimicked by the P2Y (1/12/13) agonist ADP and the P2Y 1 agonist MRS-2365, whereas the P2X (1/3) agonist α,β-methyleneadenosine-5-triphosphate only had a small effect. The P2Y 1 antagonists MRS-2279 and MRS-2500 hyperpolarised glucose-stimulated beta cells and lowered [Ca 2+ ] i in the absence of exogenously added ATP and inhibited glucose-induced insulin secretion by 35%. In voltage-clamped cells subjected to action potential-like stimulation, MRS-2279 decreased [ 
Introduction
In addition to serving as an energy carrier and intracellular signal, ATP has an important role as an extracellular signal and neurotransmitter. After its release from cells by exocytosis or via non-vesicular pathways, ATP activates two types of purinergic P2 receptors in the plasma membrane. P2X receptors are ligand-gated non-selective cation channels, while P2Y receptors are G-protein coupled. In humans, the P2X and P2Y families comprise 7 and 11 isoforms, respectively [1, 2] .
ATP is present at millimolar concentrations in insulin granules [3, 4] and is released from beta cells upon glucose stimulation [5] [6] [7] . There is evidence for the expression of both P2X and P2Y receptors in rat and mouse beta cells, suggesting that ATP acts as an autocrine signal in islets, although it is debatable whether purinergic signalling stimulates or inhibits insulin secretion [8, 9] . Overall, the few studies that have been conducted in human islets suggest a stimulatory role for ATP [10] [11] [12] . However, controversy exists regarding the receptor subtypes and signal transduction pathways involved. While one study proposed that ATP acts principally via P2X 3 receptors, membrane depolarisation and increasing the intracellular Ca 2+ concentration ([Ca 2+ ] i ) [11] , a more recent study suggested a prominent role for P2Y 1 receptors and activation of protein kinase C [12] . Involvement of P2X 7 has also been proposed [13] . An ATP-evoked, P2X-mediated membrane current in human beta cells has been suggested [14] , although the effect of ATP on glucose-induced electrical activity has not been investigated.
We sought to characterise the effects of extracellular ATP on membrane currents and membrane potential in human beta cells. We found that the effects of ATP were mimicked by the P2Y agonist ADP and demonstrated that autocrine activation of P2Y 1 receptors plays a significant role in the regulation of electrical activity, [Ca 2+ ] i and insulin secretion in human beta cells. Autocrine signalling via P2Y 1 represents a novel link between Ca 2+ influx and Ca 2+ release from intracellular stores.
Methods M a t e r i a l s M R S -2 2 7 9 , M R S -2 3 6 5 , M R S -2 5 0 0 , α,β-methyleneadenosine-5-triphosphate (α,β-meATP), 2′,3′-O-(2,4,6-trinitrophenyl)-ATP (TNP-ATP), heparin, thapsigargin and bafilomycin A1 were from R&D Systems (Minneapolis, MN, USA). Fura-2AM and Fura-2 Na + -salt were from Life Technologies (Burlington, ON, Canada). Nucleotides and other chemicals were obtained from Sigma-Aldrich (Oakville, ON, Canada).
Islet isolation, culture and transfection Human islets were from the Clinical Islet Laboratory at the University of Alberta or the Alberta Diabetes Institute IsletCore [15, 16] . The study was approved by the local Human Research Ethics Board. Islets were dispersed in Ca 2+ -free buffer and then plated onto plastic or glass-bottom Petri-dishes (In Vitro Scientific, Sunnyville, CA, USA) and incubated in RPMI-1640 medium containing 7.5 mmol/l glucose for at least 24 h before experiments. For measuring ATP release, cells were infected with an adenovirus encoding a P2X 2 -green fluorescent protein fusion protein (AdP2X 2 -GFP) for 24-48 h [5] . All experiments, except for the assessment of insulin secretion, were carried out using dispersed beta cells.
Immunohistochemistry Paraffin-embedded tissue sections were heated in 10 mmol/l Na + -citrate (pH 6) for 10 min. Sections were blocked using 20% goat serum and incubated with anti-P2Y 1 (1:50 dilution; P6487; Sigma-Aldrich) and anti-insulin antibodies for 1 h, followed by fluorescently labelled secondary antibodies. Images were captured using a Zeiss Apotome inverted microscope (Carl Zeiss Canada, Toronto, ON, Canada). Identification of beta cells by immunocytochemistry after patch-clamp and Ca 2+ imaging was as described previously [17] .
Ca
2+ imaging Cells were pre-incubated with Fura-2AM (1 μmol/l) for 15 min. Glass-bottom Petri dishes were mounted onto an inverted microscope (Zeiss Axioobserver, Carl Zeiss Canada Ltd.) equipped with an ICCD-camera and a rapid-switching light source (Oligochrome; Till Photonics, Grafelfing, Germany). Fluorophore, excited at 340 and 380 nm (intensity ratio 10:4) and emission detected at 510 nm, was imaged at 0.5 Hz using Life Acquisition software (Till Photonics). Beta cells were identified by immunostaining and fluorescence ratios were calculated using ImageJ (v1.46r; http://imagej.nih.gov/ij/).
Insulin secretion Fifteen size-matched islets (in triplicates)
were pre-incubated in 0.5 ml KRB buffer containing 1 mmol/l glucose and 0.1% BSA for 1 h, followed by a 1 h test incubation in KRB with the indicated glucose concentrations and test substances. The supernatant fraction was removed and the insulin concentration was determined using the MSD human insulin kit (Meso-Scale Discovery, Rockville, MD, USA).
Electrophysiology Patch-clamp was performed using an EPC-10 amplifier and Patchmaster software (Heka Electronics, Lambrecht, Germany). Patch-pipettes were pulled from borosilicate glass (resistance 3-8 MΩ; Sutter Instruments, Novato, CA, USA). Solutions for whole-cell and perforatedpatch recording are detailed in the electronic supplementary materials (ESM) Methods. Cells were continuously superfused (~1 ml/min) with extracellular solution at~32°C. Rapid application of ATP was performed using a Fast-Step system (Warner Instruments, Hamden, CT, USA). Beta cells were identified by immunostaining or based on cell size (12.5±0.3 pF; n=189) [17] .
PCR analysis Expression of P2Y receptors (P2RY [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] ) was analysed by RT-PCR in RNA purified from isolated human islets, using a previously described protocol [18] . Primer sequences are detailed in ESM Methods.
Data analysis Data are presented as means ± SEM. The n values represent the number of cells, unless indicated otherwise. Statistical significance was evaluated using Student's t test, or by multiple-comparison ANOVA and Bonferroni post test when comparing multiple groups.
Results
Membrane currents evoked by purinergic receptor agonists Using the whole-cell configuration in cells held at −70 mV in 6 mmol/l glucose, extracellular ATP application evoked a detectable inward current in 25% of human beta cells (15 out of 60). The maximal current amplitude was 24 pA (Fig. 1a) . In responding cells, the ATP-activated current averaged 6.7±1.7 pA and was reduced 65±17% by the P2 receptor blocker suramin (100 μmol/l; p<0.05, n=5).
In perforated-patch whole-cell recordings, ATP-evoked an inward current in all beta cells (1.2-8.6 pA) and averaged 3.4±0.7 pA (Fig. 1b) . Similar responses were obtained with the P2Y (1/12/13) agonist ADP (4.2±0.6 pA; 0.4-11.1 pA) and the P2Y 1 agonist MRS-2365 (2.4± 0.3 pA), but not the P2X (1/3) agonist α,β-meATP (Fig. 1b) . The ATP-or ADP-evoked current was inhibited 78±13% by the P2Y 1 antagonist MRS-2279 (2-3 μmol/l, p < 0.05, n =4). The ADP-evoked current was inward during voltage ramps from −110 to −60 mV (Fig. 1c, d ) and was not inhibited by tolbutamide (4.2±1.1 pA, n=4; Fig. 1e ). The rapid upstroke in Fig. 1e following application of tolbutamide and ADP is likely to be an artefact. Instead, the current was attenuated (by 90± 25%; p < 0.05, n = 5) when Na + was replaced by the membrane-impermeable cation N-methyl-D-glucamine (NMDG + ) ( Fig. 1f-h ).
Effect of purinergic agonists on the membrane potential At 6 mmol/l glucose, isolated beta cells exhibited varying degrees of action potential firing (Fig. 2) . Application of ATP (10 μmol/l) depolarised cells (from −53.7±2.2 to −39.3± 2.9 mV, Fig. 2a , e) and stimulated or augmented action potential firing. This effect was mimicked by ADP, which depolarised human beta cells from −53.6±2.1 to −38.6± 2 mV (Fig. 2b, e) . UTP, an agonist at P2Y (2/6/8) receptors, had no effect (data not shown). The 
Effect of purinergic agonists on [Ca

2+
] i At 6 mmol/l glucose, ATP induced a biphasic increase in [Ca 2+ ] i consisting of an initial rapid spike followed by a plateau (Fig. 3a) . In the absence of extracellular Ca (Fig. 3c, d, k) . In contrast bafilomycin A1, which depletes acidic Ca 2+ stores, had little effect on the [Ca 2+ ] i signal (Fig. 3e, k) . The effect of ATP on [Ca 2+ ] i was mimicked by ADP and MRS-2365 (Fig. 3f, h, k) . UTP and α,β-meATP evoked only small responses (Fig. 3g, i, k) . Beta cells from a donor with type 2 diabetes were observed to have an ATP-sensitive Ca 2+ response that appeared smaller than the response of healthy beta cells, but did not attain statistical significance and lacked the initial rapid spike (Fig. 3j) .
To ] i increase evoked by extracellular ATP was completely suppressed by heparin (Fig. 4a, b) , suggesting that the ATP-evoked [Ca 2+ ] i spike results from InsP 3 -dependent endoplasmic reticulum (ER) Ca 2+ release while the plateau is due to Ca 2+ influx through plasma membrane channels.
Effect of ATP on exocytosis Exocytosis was elicited by voltage-clamp depolarisations from −70 to 0 mV, which triggers Ca 2+ influx through voltage-gated Ca 2+ channels. Exocytosis was potentiated 64% and 32% by extracellular application of ATP and ADP, respectively (Fig. 4c, d ). We next monitored the membrane capacitance in cells clamped at −70 mV to prevent opening of voltage-gated Ca 2+ channels, and in the presence of 5 mmol/l glucose. ATP application alone was sufficient to evoke a clear exocytotic response under these conditions (Fig. 4e) . This response was strongly inhibited in cells pretreated with thapsigargin (Fig. 4f) . RT-PCR. Transcripts were identified for P2Y 1 , P2Y 2 , P2Y 11 and P2Y 14 (Fig. 5a ). The expression of P2Y 1 in beta cells was confirmed by co-immunostaining of human pancreatic tissue sections with anti-P2Y 1 and anti-insulin (Fig. 5b) .
Expression of P2Y receptors in human beta cells Expression of P2Y receptor isoforms in human islets was analysed by
Exocytotic release of ATP Rat and mouse beta cells release ATP by Ca
2+
-dependent exocytosis of insulin granules [5-7, 19, 20] . To examine whether ATP is secreted from human beta cells we overexpressed P2X 2 receptors [6, 7] and stimulated exocytosis by infusion of Ca 2+ (2 μmol/l) via the patch pipette. Resultant transient inward currents were blocked by the P2 antagonist suramin ( Fig. 6a; n=4) . These events reflect release of ATP from single insulin granules [5, 7] . Beta cells were then incubated in 1 or 10 mmol/l glucose for 1 h with 100 μmol/l diazoxide to prevent K AT P -mediated depolarisation. To avoid artefacts resulting from P2X 2 receptor overexpression, transient inward currents were compared with the current produced by 300 μmol/l ATP. Upon infusion of Ca 2+ (2 μmol/l) the ATP release events were larger (Fig. 6c,   p<0 .05) and tended to be more frequent (Fig. 6d) following glucose stimulation. ] i in beta cells stimulated with 6 mmol/l glucose (Fig. 7a) . Both MRS-2279 and MRS-2500 reversibly hyperpolarised the beta cells in the absence of exogenous ATP and inhibited glucose-induced electrical activity (Fig. 7b) . The P2Y 1 receptor antagonists decreased the membrane potential by 3.5±1.4 mV (from −47.4±2.8 to −50.8± 2.2 mV, p<0.05; Fig. 7b ). In control experiments, the P2Y 1 antagonists had no direct effects on voltage-gated Ca 2+ , Na + or K + currents or on K ATP current in human beta cells (ESM Fig. 1 ). In islets from four donors, MRS-2500 reduced the secretory response to glucose by 35% (Fig. 7c) . ] i was monitored during a series of short depolarisations mimicking glucose-induced electrical activity. In four of nine cells, the capacitance increase was nearly linear and ceased immediately after the end of the stimulation (Fig. 8a ) and the [Ca 2+ ] i signal plateaued after a steep initial rise, returning to baseline with a time constant (τ) of~2 s. In these cells neither [Ca 2+ ] i signal nor exocytosis and Ca 2+ influx were affected by MRS-2279 (Fig. 8a, c-f ). In five of nine cells, both exocytotic response and [Ca 2+ ] i signal displayed a secondary acceleration during the second half of the stimulation (Fig. 8b) ; also, the [Ca 2+ ] i signal returned to baseline with a significantly slower τ (~4 s).
In these cells MRS-2279 strongly and reversibly inhibited exocytosis, the [Ca
2+
] i response and the τ of [Ca 2+ ] i decline to levels observed in cells lacking secondary acceleration (Fig. 8b-f ) . The Ca 2+ influx evoked by the depolarisations was not different between groups of cells (and unaffected by MRS-2279; Fig. 8f ).
Discussion
This study provides evidence that ATP acts as a positive autocrine feedback signal in human beta cells, by amplifying ] i , while the P2X (1/3) agonist α,β-meATP did not; (3) P2Y 1 inhibition blocked the ATP-evoked membrane depolarisation; (4) MRS-2500 reduced insulin secretion to a similar extent as the non-specific P2 antagonist suramin [11] . While in ] i (at 6 mmol/l glucose). (b) Effect of MRS-2279 and MRS-2500 (both at 1 μmol/l) on glucose (6 mmol/l)-induced electrical activity (n=8). (c) Insulin secretion was measured from isolated human islets at 1 and 8 mmol/l glucose (Gluc) in the absence and presence of MRS-2500 (n=4 donors). Data are from three to six donors. **p<0.01 and ***p<0.001 compared with 1 mmol/l glucose or as indicated agreement with the findings of a recent study [12] , our findings vary from those of another study suggesting a dominant role for P2X 3 [11] . However, the latter study employed pyridoxalphosphate-6-azophenyl-2′,5′-disulfonic acid (iso-PPADS) and oxidised ATP at concentrations that also strongly inhibit P2Y 1 [21, 22] . The more selective P2X (1/3) blocker TNP-ATP [23] does not affect [Ca 2+ ] i (Fig. 7a) . While others have also suggested a role for P2X 7 [13] , human P2X 7 has a very low affinity for ATP (half maximal effective concentration [ED 50 ] 0.78 mmol/l) and is insensitive to ADP and AMP [24] , making a role for P2X 7 unlikely here. P2Y 1 has a~20-fold lower affinity for ATP than P2X 3 [1, 2] . However, it has been reported that insulin granules contain similar concentrations of ATP and ADP [3] , suggesting that ] i , and the magnitude of ATP-release events was increased by glucose. This could result from intragranular ATP accumulation via granule-resident vesicular nucleotide transporter [25] . It should be noted, however, that in intact rodent islets extracellular ATP plays an important role in synchronising the electrical and Ca 2+ responses among beta cells within and between islets through the induction of Ca 2+ release from InsP 3 -sensitive stores [26] [27] [28] , in addition to stimulating exocytosis.
Some studies conducted in rodents, particularly mice, have found that ATP inhibits insulin secretion [8] and that insulin secretion in islets from mice lacking P2Y 1 is elevated [29] . This was attributed to direct inhibitory effects of ATP on exocytosis [30] or voltage-gated Ca 2+ currents [31] . It has been reported that adenosine, acting on P1 receptors, inhibits insulin secretion from INS-1 cells [32] , but this was not confirmed in human islets [11] . We show here that ATP stimulates depolarisation-evoked exocytosis without affecting Ca 2+ currents in human beta cells. We found no evidence for a negative role of ATP in insulin secretion from human islets, consistent with the potentiation of insulin secretion from human islets following block of extracellular ATP degradation [11, 33] .
ATP increased [Ca 2+ ] i in a biphasic manner, with an initial peak reflecting Ca 2+ release from stores and a plateau reflecting Ca 2+ influx. Similar to rat beta cells [34] , Ca 2+ was released via heparin-sensitive InsP 3 receptors, but was from thapsigargin-sensitive (ER) rather than bafilomycinsensitive (acidic) compartments. Our findings differ from those of Jacques-Silva et al, who concluded that Ca 2+ stores contribute little to the ATP-evoked Ca 2+ signal in human beta cells [11] , but this may be explained by experimental differences: the Ca 2+ response under Ca
2+
-free conditions is transient and will appear small (as AUC) when compared with prolonged agonist application in the presence of extracellular Ca
. Although a recent study suggests that autocrine activation of P2Y 1 stimulates diacylglycerol production in rodent and human beta cells [12] , we were unable to determine a role for phospholipase C as the inhibitor U-73122 (5-10 μmol/l) also suppressed KCl-evoked Ca 2+ responses (data not shown). In mice, P2Y 1 receptors depolarise beta cells via inhibition of K ATP channels [30] . In contrast, the ADP-evoked membrane current in human beta cells did not reverse at the K + equilibrium potential and was insensitive to tolbutamide. Instead, the current was abolished by removal or replacement of Na + , indicating a Na + -or non-selective cation conductance similar to P2Y 1 -activated currents in neurons [35] [36] [37] . This effect was insensitive to thapsigargin (arguing against a storeoperated channel) and to Gd 3+ , a blocker of the Na + leak channel NALCN [38] . While the molecular identity of the P2Y 1 -activated leak channel remains unclear, candidates include members of the transient receptor potential channel family [39] .
We now show that blocking P2Y 1 receptors also inhibits electrical activity, [Ca 2+ ] i signalling and insulin secretion in human beta cells in the absence of exogenous ATP (Fig. 7) . While P2Y 1 blockade inhibits spontaneous [Ca 2+ ] i transients in mouse beta cells [40] , this was in the presence of a Ca 2+ channel blocker and thus not likely caused by electrical activity and Ca 2+ influx. We obtained similar results with two different, selective P2Y 1 antagonists [41, 42] that lacked non-specific effects on a number of human beta cell ion channels (ESM Fig. 1) .
In cells stimulated with action potential-like depolarisations, P2Y 1 blockade reduces [Ca 2+ ] i and exocytosis without affecting Ca 2+ currents (Fig. 8) . Thus the MRS-2279-sensitive component of the [Ca 2+ ] i increase reflects Ca 2+ release from stores triggered by autocrine activation of P2Y 1 receptors. This, in combination with activation of diacylglycerol and protein kinase C (DAG/ PKC) [12] , potentiates exocytosis. The Ca 2+ signal required for insulin secretion is largely generated by Ca 2+ influx through voltage-gated Ca 2+ channels [43, 44] ; our results are compatible with this because membrane depolarisation and Ca 2+ influx are necessary to evoke ATP release and initiate the feedback loop. The secondary acceleration of depolarisation-evoked exocytosis, which we suggest reflects ER Ca 2+ release, is observed in human [17, 45] Duality of interest The authors declare that there is no duality of interest associated with this manuscript.
